AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Chronic Outcome Monitoring for DBS in Dystonia

Recruitingn/aAges 5 Years - 80 YearsAllCharite University, Berlin, Germany
💬

In plain words

What the trial is, and whether it could suit you

Dystonia is a severe movement disorder involving increased muscular activity and can be very variable. To date, the treatment of dystonia is challenging. One effective therapy is deep brain stimulation (DBS), an invasive therapy, where stimulation electrodes are inserted in deep brain regions and a continuous electrical therapy is delivered via a pacemaker. However, the optimization of the therapy is a long process, up to months and there is no immediate adaptation to different disease states. This project aims to improve DBS therapy: The first aim is to learn more about electrical brain activity that could be the feedback signal for individualized therapy. Secondly, the investigators want to gather information about the long-term development of the signal and potential hints for optimal therapy locations that could be acutely used to accelerate therapy optimization. To date, recordings

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Ability to give informed consent for the study, or in pediatric patients, legal guardian or parent willing to give informed consent * Diagnosis of dystonia, which may be isolated or generalized * Wish to receive surgical intervention with DBS to the internal pallidal globe (GPi) * Decision to receive the sensing-enabled neurostimulator (Percept neurostimulator) PC/RC * Age 5-80 years Exclusion Criteria: * Severe psychiatric disorders (BDI\>20) * Other severe medical conditions, that may interfere with the successful paritcipation in the study protocol * No consent given
💊

What it tests

  • Not listed
📍

Where

3 sites
Medizinische Hochschule Hannover
Hanover, Germany
Heinrich Heine University
Düsseldorf, Germany
Charité Universitätsmedizin Berlin
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy